Systematic review and meta-analysis of the impact of depression on subsequent smoking cessation in patients with coronary heart disease: 1990 to 2013

Psychosomatic Medicine

Volumn 76, Issue 1, 2014, Pages 44-57

  Doyle, Frank ^a   Rohde, Daniela ^a   Rutkowska, Aleksandra ^a   Morgan, Karen ^b   Cousins, Grainne ^a   McGee, Hannah ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b PERDANA UNIVERSITY   (Malaysia)

Author keywords

coronary heart disease; depression; health behaviors; smoking; smoking cessation

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; BECK DEPRESSION INVENTORY; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; DEPRESSION; FOLLOW UP; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTERVIEW; ISCHEMIC HEART DISEASE; META ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY ANALYSIS; SMOKING; SMOKING CESSATION; SYSTEMATIC REVIEW;

CORONARY HEART DISEASE; DEPRESSION; HEALTH BEHAVIORS; SMOKING; SMOKING CESSATION;

CORONARY DISEASE; DEPRESSION; HUMANS; SMOKING; SMOKING CESSATION;

EID: 84892952727     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0000000000000020     Document Type: Article

References (65)

1. Rigotti NA, Clair C, Munafo MR, Stead LF. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev 2012;5: CD001837.
2. Pipe AL, Papadakis S, Reid RD. The role of smoking cessation in the prevention of coronary artery disease. Curr Atherosclerosis Rep 2010;12: 145-50.
3. Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. Arch Intern Med 2000;160:939-44.
4. Busch AM, Borrelli B, Leventhal AM. The relationship between smoking and depression postYacute coronary syndrome. Curr Cardiovasc Risk Rep 2012;5:510-8.
5. Freedland KE, Carney RM, Skala JA. Depression and smoking in coronary heart disease. Psychosom Med 2005;67(suppl 1):S42-6.
6. Thorndike AN, Rigotti NA. A tragic triad: coronary artery disease, nicotine addiction, and depression. Curr Opinion Cardiol 2009;24:447-53.
7. Milionis HJ, Rizos E, Mikhailidis DP. Smoking diminishes the beneficial effect of statins: observations from the landmark trials. Angiology 2001;52: 575-87.
8. Journath G, Nilsson PM, Petersson U, Paradis BA, Theobald H, Erhardt L. Hypertensive smokers have a worse cardiovascular risk profile than non-smokers in spite of treatmentVa national study in Sweden. Blood Press 2005;14:144-50.
9. Centers for Disease Control and Prevention. QuickStats: Prevalence of Current Depression* Among Persons Aged Q12 Years, by Age Group and Sex-United States, National Health and Nutrition Examination Survey 2007-2010. National Center for Health Statistics, January 6, 2012.
10. Meijer A, Conradi HJ, Bos EH, Anselmino M, Carney R, Denollet J, Doyle F, Freedland KE, Grace SL, Hosseini SH, Lane DA, Pilote L, Parakh K, Rafanelli C, Sato H, Steeds RP, Welin C, de Jonge P. Adjusted prognostic association of post-myocardial infarction depression with mortality and cardiovascular events: an individual patient data meta-analysis. Br J Psychiat 2013;203:90-102.
11. Thorndike AN, Regan S, McKool K, Pasternak RC, Swartz S, Torres-Finnerty N, Rigotti NA. Depressive symptoms and smoking cessation after hospitalization for cardiovascular disease. Arch Intern Med 2008;168: 186-91.
12. Trockel M, Burg M, Jaffe A, Barbour K, Taylor C. Smoking behavior postmyocardial infarction among ENRICHD trial participants: cognitive behavior therapy intervention for depression and low perceived social support compared with care as usual. Psychosom Med 2008;70: 875-82.
13. Hughes JR. Depression during tobacco abstinence. Nicotine Tobacco Res 2007;9:443-6.
14. AAFP. AAFP guideline for the detection and management of postYmyocardial infarction depression. Ann Fam Med 2009;7:71-9.
15. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283: 2008-12.
16. Ades PA, Waldmann ML, McCann WJ, Weaver SO. Predictors of cardiac rehabilitation participation in older coronary patients. Arch Intern Med 1992;152:1033-5.
17. Clark AM, King-Shier KM, Duncan A, Spaling M, Stone JA, Jaglal S, Angus J. Factors influencing referral to cardiac rehabilitation and secondary prevention programs: a systematic review. Eur J Prev Cardiol 2013;20:692-700.
18. Clark AM, King-Shier KM, Spaling MA, Duncan AS, Stone JA, Jaglal SB, Thompson DR, Angus JE. Factors influencing participation in cardiac rehabilitation programmes after referral and initial attendance: qualitative systematic review and meta-synthesis. Clin Rehabil 2013;27:948-59.
19. Crowe M, Sheppard L. A general critical appraisal tool: an evaluation of construct validity. Int J Nurs Stud 2011;48:1505-16.
20. Crowe M, Sheppard L, Campbell A. Comparison of the effects of using the Crowe Critical Appraisal Tool versus informal appraisal in assessing health research: a randomised trial. Int J Evidence Based Health 2011;9:444-9.
21. Crowe M, Sheppard L, Campbell A. Reliability analysis for a proposed critical appraisal tool demonstrated value for diverse research designs. J Clin Epidemiol 2012;65:375-83.
22. Kontopantelis E, Reeves D. METAEFF: Stata module to perform effect sizes calculations for meta-analyses. March 24, 2011 ed2009. Available at: http://econpapers.repec.org/software/bocbocode/s457072.htm.
23. Sterne JAC. Meta-Analysis in Stata: An Updated Collection from the Stata Journal. College Station, TX: Stata Press; 2009.
24. Tak LM, Meijer A, Manoharan A, de Jonge P, Rosmalen JG. More than the sum of its parts: meta-analysis and its potential to discover sources of heterogeneity in psychosomatic medicine. Psychosom Med 2010;72:253-65.
25. Attebring MF, Hartford M, Hjalmarson A, Caidahl K, Karlsson T, Herlitz J. Smoking habits and predictors of continued smoking in patients with acute coronary syndromes. J Adv Nurs 2004;46:614-23.
26. Berndt N, Bolman C, Mudde A, Verheugt F, de Vries H, Lechner L. Risk groups and predictors of short-term abstinence from smoking in patients with coronary heart disease. Heart Lung 2012;41:332-43.
27. Berndt N, Hayes AF, Verboon P, Lechner L, Bolman C, de Vries H. Self-efficacy mediates the impact of craving on smoking abstinence in low to moderately anxious patients: results of a moderated mediation approach. Psychol Addict Behav 2012;27:113-24.
28. Brummett BH, Babyak MA, Mark DC, Williams RB, Siegler IC, Clapp-Channing N, Barefoot JC. Predictors of smoking cessation in patients with a diagnosis of coronary artery disease. J Cardiopulm Rehabil 2002;22:143-7.
29. Dawood N, Vaccarino V, Reid KJ, Spertus JA, Hamid N, Parashar S. Predictors of smoking cessation after a myocardial infarction: the role of institutional smoking cessation programs in improving success. Arch Intern Med 2008;168:1961-7.
30. Gravely-Witte S, Stewart DE, Suskin N, Grace SL. The association among depressive symptoms, smoking status and antidepressant use in cardiac outpatients. J Beh Med 2009;32:478-90.
31. Holtrop JS, Stommel M, Corser W, Holmes-Rovner M. Predictors of smoking cessation and relapse after hospitalization for acute coronary syndrome. J Hosp Med 2009;4:E3-9.
32. Huijbrechts IP, Duivenvoorden HJ, Deckers JW, Leenders IC, Pop GA, Passchier J, Erdman RA. Modification of smoking habits five months after myocardial infarction: relationship with personality characteristics. J Psychosom Res 1996;40:369-78.
33. Jones DA, West RR. Psychological rehabilitation after myocardial infarction: multicentre randomised controlled trial. BMJ 1996;313:1517-21.
34. Kronish IM, Rieckmann N, Halm EA, Shimbo D, Vorchheimer D, Haas DC, Davidson KW. Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes. J Gen Intern Med 2006;21:1178-83.
35. Ladwig KH, Roll G, Breithardt G, Budde T, Borggrefe M. Post-infarction depression and incomplete recovery 6 months after acute myocardial infarction. Lancet 1994;343:20-3.
36. Mayou RA, Gill D, Thompson DR, Day A, Hicks N, Volmink J, Neil A. Depression and anxiety as predictors of outcome after myocardial infarction. Psychosom Med 2000;62:212-9.
37. McGee HM, Doyle F, Conroy RM, De La Harpe D, Shelley E. Impact of briefly-assessed depression on secondary prevention outcomes after acute coronary syndrome: a one-year longitudinal survey. BMC Health Serv Res 2006;6:9.
38. Gerber Y, Koren-Morag N, Myers V, Benyamini Y, Goldbourt U, Drory Y. Long-term predictors of smoking cessation in a cohort of myocardial infarction survivors: a longitudinal study. Eur J Cardiovasc Prev Rehab 2011;18:533-41.
39. Myers V, Gerber Y, Benyamini Y, Goldbourt U, Drory Y. Post-myocardial infarction depression: increased hospital admissions and reduced adoption of secondary prevention measuresVa longitudinal study. J Psychosom Res 2012;72:5-10.
40. Pedersen SS, Deckers JW, van Os F, Erdman RAM. A multifactorial smoking cessation programme for patients with coronary artery disease: experiences and preliminary results. Neth Heart J 2002;10:48-53.
41. Perez GH, Nicolau JC, Romano BW, Laranjeira R. Depression: a predictor of smoking relapse in a 6-month follow-up after hospitalization for acute coronary syndrome. Eur J Cardiovasc Prev Rehabil 2008;15:89-94.
42. Taylor D, Barber K, McIntosh B, Khan M. The impact of post acute myocardial infarction (AMI) depression on patient compliance and risk factor modification. Psychol Health Med 1998;3:439-42.
43. Ziegelstein RC, Fauerbach JA, Stevens SS, Romanelli J, Richter DP, Bush DE. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Int Med 2000;160:1818-23.
44. Romanelli J, Fauerbach JA, Bush DE, Ziegelstein RC. The significance of depression in older patients after myocardial infarction. J Am Geriatric Soc 2002;50:817-22.
45. Fogel J, Fauerbach JA, Ziegelstein RC, Bush DE. Quality of life in physical health domains predicts adherence among myocardial infarction patients even after adjusting for depressive symptoms. J Psychosom Res 2004; 56:75-82.
46. Kuhl EA, Fauerbach JA, Bush DE, Ziegelstein RC. Relation of anxiety and adherence to risk-reducing recommendations following myocardial infarction. Am J Cardiol 2009;103:1629-34.
47. Brummett BH, Babyak MA, Siegler IC, Mark DB, Williams RB, Barefoot JC. Effect of smoking and sedentary behavior on the association between depressive symptoms and mortality from coronary heart disease. Am J Cardiol 2003;92:529-32.
48. Stafford L, Jackson HJ, Berk M. Illness beliefs about heart disease and adherence to secondary prevention regimens. Psychosom Med 2008;70: 942-8.
49. Ramaekers BL, Janssen-Boyne JJ, Gorgels AP, Vrijhoef HJ. Adherence among telemonitored patients with heart failure to pharmacological and nonpharmacological recommendations. Telemed J E Health 2009;15: 517-24.
50. Nikolic G, Samardzic L, Jovanovic T. Changes in psychological parameters and health behavior of coronary and non-coronary patients following hospitalizationVa six month follow-up. Acta Med Medianae 2012;51:12-9.
51. The ENRICHD Investigators. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA 2003;289:3106-16.
52. Wu P, Wilson K, Dimoulas P, Mills EJ. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health 2006;6:300.
53. Katrak P, Bialocerkowski AE, Massy-Westropp N, Kumar S, Grimmer KA. A systematic review of the content of critical appraisal tools. BMC Med Res Method 2004;4:22.
54. Moja LP, Telaro E, D'Amico R, Moschetti I, Coe L, Liberati A. Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional study. BMJ 2005;330:1053.
55. Patrick DL, Cheadle A, Thompson DC, Diehr P, Koepsell T, Kinne S. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health 1994;84:1086-93.
56. Doyle F, Conroy R, McGee H. Differential predictive value of depressive versus anxiety symptoms in the prediction of 8-year mortality after acute coronary syndrome. Psychosom Med 2012;74:711-6.
57. Doyle F, Conroy R, McGee H. Challenges in reducing depression-related mortality in cardiac populations: cognition, emotion, fatigue or personality? Health Psychol Rev 2007;1:137-72.
58. West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005;100:299-303.
59. Patton GC, Carlin JB, Coffey C, Wolfe R, Hibbert M, Bowes G. Depression, anxiety, and smoking initiation: a prospective study over 3 years. Am J Public Health 1998;88:1518-22.
60. Mohiuddin SM, Mooss AN, Hunter CB, Grollmes TL, Cloutier DA, Hilleman DE. Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. Chest 2007;131:446-52.
61. Bartels C, Abuhaliga AR, McGee H, Morgan K, McElvaney NG, Doyle F. A survey of the prevalence of smoking and smoking cessation advice received by inpatients in a large teaching hospital in Ireland. Ir J Med Sci 2012;181:445-9.
62. Reid RD, Mullen KA, Slovinec D'Angelo ME, Aitken DA, Papadakis S, Haley PM, McLaughlin CA, Pipe AL. Smoking cessation for hospitalized smokers: an evaluation of the "Ottawa Model." Nicotine Tobacco Res 2010;12:11-8.
63. Freedland KE, Carney RM. Depression as a risk factor for adverse outcomes in coronary heart disease. BMC Med 2013;11:131.
64. Meijer A, Zuidersma M, Jonge P. Depression as a non-causal variable risk marker in coronary heart disease. BMC Med 2013;11:130.
65. Skala JA, Freedland KE, Carney RM. Coronary heart disease and depression: a review of recent mechanistic research. Can J Psychiat 2006;51:738-45.